# Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

> **NCT01965002** · NA · TERMINATED · sponsor: **Pejman Ghanouni** · enrollment: 5 (actual)

## Conditions studied

- Soft Tissue Neoplasms

## Interventions

- **DEVICE:** MRgHIFU
- **DRUG:** Aspirin
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT01965002
- **Lead sponsor:** Pejman Ghanouni
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2015-03-24
- **Final completion:** 2015-03-24
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Accrual factor
- **Last updated:** 2018-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01965002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01965002, "Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01965002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*